𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Remission induction chemotherapy in acute myeloid leukemia: Preliminary results

✍ Scribed by P. Dujardin; M. Schneider; P. Audoly

Book ID
113145885
Publisher
Elsevier Science
Year
1977
Weight
123 KB
Volume
13
Category
Article
ISSN
0014-2964

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Impact of remission induction chemothera
Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia
✍ Rachid Baz; Cristina Rodriguez; Alex Z. Fu; Rony Abou Jawde; Matt Kalaycio; Anja πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 124 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. Significant controversy surrounds the use of remission induction chemotherapy (IC) in older adults with acute myeloid leukemia (AML). Earlier clinical trials have yielded conflicting results and possibly a minor survival benefit, often offset by a longer hospitalization

Intensive timed sequential remission ind
Intensive timed sequential remission induction chemotherapy with high-dose cytarabine for childhood acute myeloid leukemia
✍ Loeb, David M. ;Bowers, Daniel C. ;Civin, Curt I. ;Friedman, Alan D. πŸ“‚ Article πŸ“… 2001 πŸ› John Wiley and Sons 🌐 English βš– 91 KB

## Background: Timed sequential chemotherapy and high-dose cytarabine (cytosine arabinoside, ara-c; hdac) are both effective treatments for acute myeloid leukemia (aml). we review our institutional experience with timed sequential induction chemotherapy consisting of daunorubicin/ara-c/-thioguanine